As illustrated in Fig. 8, based on clinical observations presented in Figs. 1 and 2, this study explored the molecular and cellular mechanisms by which ARRB2 was negatively implicated in lung cancer progression induced by TLR3 and TLR4 and proposed a possible model. This evidence concerns the gene TLR4 and lung carcinoma.